Abstract
The presence of an immunosuppressive microenvironment can limit the full potential of adoptive T cell immunotherapy. However, specific blockade of the PD-1 immunosuppressive pathway can significantly enhance the function of gene-modified T cells expressing a chimeric antigen receptor (CAR) leading to enhanced tumor eradication.
Cite
CITATION STYLE
APA
John, L. B., Kershaw, M. H., & Darcy, P. K. (2013). Blockade of PD-1 immunosuppression boosts CAR T-cell therapy. OncoImmunology, 2(10), e26286. https://doi.org/10.4161/onci.26286
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free